Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Subst Use Misuse. 2013 Apr 12;48(7):523–531. doi: 10.3109/10826084.2013.787094

TABLE 5.

Demographic and injection characteristics of 544 California injection drug users self-reporting treatment of previous lifetime abscess, California, 2003–2005

Characteristic or practice Did not
self-treat last
abscess
(n = 283)
Self-treated
prior abscess
(n = 261)
P-value
Age 0.21
  <30 years 8 (2.9) 14 (5.4)
  30–39 years 41 (14.7) 33 (12.7)
  40–49 years 101 (36.2) 108 (41.5)
  50+ years 129 (46.2) 105 (40.4)
Race 0.004
  White 54 (19.4) 55 (21.5)
  Black 116 (41.6) 70 (27.3)
  Latino 92 (33.0) 116 (45.3)
  Other 17 (6.1) 15 (5.9)
Gender 0.32
  Male 203 (71.7) 177 (67.8)
  Female 80 (28.3) 84 (32.2)
Homeless 0.67
  No 128 (46.0) 114 (44.2)
  Yes 150 (54.0) 144 (55.8)
SEP client 0.95
  No 95 (33.6) 87 (33.3)
  Yes 188 (66.4) 174 (66.7)
Years of injecting 0.43
  <10 years 28 (10.0) 33 (12.7)
  10–19 years 52 (18.6) 40 (15.4)
  20+ years 199 (71.3) 187 (71.9)
Injection frequency 0.01
  1–29 a month 61 (21.7) 32 (12.3)
  30–89 a month 85 (30.3) 84 (32.2)
  90+ a month 135 (48.0) 145 (55.6)
Medical care 0.0007
  No usual place for care 80 (28.3) 110 (42.2)
  Have a usual place for care 203 (71.7) 151 (57.9)
Usual place of care < 0.0001
  Private doctor’s office 12 (5.9) 24 (15.9)
  Community clinic 55 (27.1) 42 (27.8)
  Hospital outpatient clinic 60 (29.6) 24 (15.9)
  Emergency room 49 (24.1) 44 (29.1)
  Syringe exchange program 0(0.0) 4 (2.6)
  Other 23 (11.3) 19 (12.6)
  Refuse to answer 4 (2.0) 6 (4.0)
Insurance 0.20
  No insurance 161 (56.9) 162 (62.3)
  Insured 122 (43.1) 98 (37.7)